AstraZeneca

FDA starts speedy review of Enhertu in lung cancer
Pharmaforum
Tue, 04/19/22 - 10:54 am
AstraZeneca
Daiichi Sankyo
FDA
non-small cell lung cancer
Enhertu
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven
Fierce Biotech
Mon, 04/18/22 - 10:48 am
AstraZeneca
Alexion
Arvinas
Connecticut
AstraZeneca bets $25M on preclinical bispecific against hot target, docking in Chinese Harbour to land global rights
Fierce Biotech
Thu, 04/7/22 - 11:16 am
AstraZeneca
Harbour BioMed
bispecifics
ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late
EP Vantage
Tue, 04/5/22 - 10:59 am
AstraZeneca
Ionis Pharmaceuticals
AZD8233
cholesterol
ACC
Amgen
Sanofi
Novartis
Regeneron
AACR Preview: AstraZeneca to Showcase "Oncology Revolution"
BioSpace
Mon, 03/28/22 - 07:48 pm
AstraZeneca
oncology
AACR
AstraZeneca's Imfinzi Fails to Boost Survival in Cervical Cancer
BioSpace
Thu, 03/24/22 - 11:44 am
AstraZeneca
Imfinizi
cervical cancer
clinical trials
AstraZeneca doubles down on digital health in its latest collaboration
Endpoints
Wed, 03/23/22 - 10:53 pm
AstraZeneca
digital health
Huma Therapeutics
decentralized clinical trials
AstraZeneca antibody drug effective against BA.2, study finds
Beckers Hospital Review
Mon, 03/21/22 - 10:37 pm
AstraZeneca
Evusheld
Omicron variant
Omicron BA.2
COVID-19
Bristol Myers sues AstraZeneca over cancer-treatment patents
Reuters
Mon, 03/21/22 - 10:08 am
Bristol Myers Squibb
AstraZeneca
cancer
patents
legal
AstraZeneca prepared to ditch effort to secure US approval for Covid vaccine
Financial Times
Thu, 03/17/22 - 11:35 pm
AstraZeneca
vaccines
COVID-19
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Fierce Pharma
Thu, 03/17/22 - 10:38 am
AstraZeneca
Roche
Chugai
Ultomiris
patents
AstraZeneca throws open doors to new ideas in global postdoc challenge
Fierce Biotech
Thu, 03/17/22 - 10:32 am
AstraZeneca
R&D
FDA clears first generic of AZ’s blockbuster Symbicort
Pharmaforum
Wed, 03/16/22 - 10:21 am
Viatris
AstraZeneca
generics
FDA
Symbicort
FDA clears AstraZeneca, Merck drug to treat some genetic breast cancers early
BioPharma Dive
Mon, 03/14/22 - 10:26 am
AstraZeneca
Merck
Lynparza
genetic breast cancer
FDA
FDA says no to AZ’s Fasenra for nasal polyp indication
Pharmaforum
Mon, 03/14/22 - 10:19 am
AstraZeneca
Fasenra
nasal polyps
Ukraine pharma CEO urges the industry to rally behind his country on three fronts
Fierce Pharma
Mon, 03/7/22 - 11:19 pm
Ukraine
Russia
biotech
AstraZeneca
AstraZeneca to tack on another $100M to wrap up over-budget R&D center
Fierce Biotech
Mon, 03/7/22 - 10:42 am
AstraZeneca
R&D
UK
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
Europe
AstraZeneca
Farxiga
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
Sanofi, AstraZeneca Express Optimism Over Phase III Infant RSV Results
BioSpace
Thu, 03/3/22 - 10:24 am
Sanofi
AstraZeneca
nirsevimab
vaccines
RSV
clinical trials

Pages